Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs

Cancer shared this article with you from Inoreader Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs Via MedWorm Cancer & Oncology Clinical Trials Condition:   Pancreatic Cancer Interventions:   Device: Microsieve device;   Device: Cell surface marker-based platform Sponsors:   Singapore General Hospital;   Agency for Science, Technology and Research Not yet recruiting (Source: ClinicalTrials.gov) View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.